PL3307275T3 - Postacie użytkowe antybiotyków do wstrzykiwania i ich zastosowanie - Google Patents

Postacie użytkowe antybiotyków do wstrzykiwania i ich zastosowanie

Info

Publication number
PL3307275T3
PL3307275T3 PL16808396T PL16808396T PL3307275T3 PL 3307275 T3 PL3307275 T3 PL 3307275T3 PL 16808396 T PL16808396 T PL 16808396T PL 16808396 T PL16808396 T PL 16808396T PL 3307275 T3 PL3307275 T3 PL 3307275T3
Authority
PL
Poland
Prior art keywords
antibiotic formulations
injectable antibiotic
injectable
formulations
antibiotic
Prior art date
Application number
PL16808396T
Other languages
English (en)
Inventor
Douglas I. Hepler
Neil E. Paulsen
Gail L. Dempsey
Michael S. Daniel
Tiffany G. Tomlinson
Ray Petzold
Original Assignee
Piedmont Animal Health Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piedmont Animal Health Inc. filed Critical Piedmont Animal Health Inc.
Publication of PL3307275T3 publication Critical patent/PL3307275T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL16808396T 2015-06-10 2016-06-10 Postacie użytkowe antybiotyków do wstrzykiwania i ich zastosowanie PL3307275T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562173850P 2015-06-10 2015-06-10
US201662307284P 2016-03-11 2016-03-11
US201662312382P 2016-03-23 2016-03-23
PCT/US2016/036936 WO2016201259A1 (en) 2015-06-10 2016-06-10 Injectable antibiotic formulations and use thereof
EP16808396.2A EP3307275B1 (en) 2015-06-10 2016-06-10 Injectable antibiotic formulations and use thereof

Publications (1)

Publication Number Publication Date
PL3307275T3 true PL3307275T3 (pl) 2021-11-02

Family

ID=57504248

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16808396T PL3307275T3 (pl) 2015-06-10 2016-06-10 Postacie użytkowe antybiotyków do wstrzykiwania i ich zastosowanie

Country Status (8)

Country Link
US (7) US10286003B2 (pl)
EP (1) EP3307275B1 (pl)
JP (1) JP6777734B2 (pl)
AU (1) AU2016274949B2 (pl)
CA (1) CA2988575C (pl)
ES (1) ES2882578T3 (pl)
PL (1) PL3307275T3 (pl)
WO (1) WO2016201259A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016201259A1 (en) * 2015-06-10 2016-12-15 Piedmont Pharmaceuticals Llc Injectable antibiotic formulations and use thereof
WO2018165477A1 (en) * 2017-03-10 2018-09-13 Piedmont Animal Health, Llc Injectable antibiotic formulations and use thereof
ES2984268T3 (es) * 2017-08-09 2024-10-29 Dechra Veterinary Products Llc Formulaciones terapéuticas que comprenden un inhibidor de la COX-2 y usos de las mismas

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ283160A (en) * 1994-05-06 1998-07-28 Pfizer Azithromycin in a controlled release dosage form for treating microbiol infections
DE69818093T2 (de) * 1997-12-03 2004-06-09 Merck & Co., Inc. Langwirkende, injizierbare, formulierungen enthaltend rizinusöl
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
WO2002007736A1 (en) * 2000-07-24 2002-01-31 Cadila Pharmaceuticals Limited The process for manufacturing of clear liquid pharmaceutical composition of azithromycin
AU2004287439A1 (en) 2003-10-29 2005-05-19 Idexx Laboratories, Inc. Salts of pharmacologically active compounds
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
KR100866728B1 (ko) 2004-11-12 2008-11-03 주식회사종근당 타크로리무스를 함유하는 주사제
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
AU2007293068C1 (en) * 2006-09-07 2013-09-19 Boehringer Ingelheim Animal Health USA Inc. Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations
US7919522B2 (en) 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
CA2694403C (en) * 2007-07-25 2013-09-24 Ixodes Gmbh Topical antibiotic composition for the prevention of lyme disease
WO2016201259A1 (en) * 2015-06-10 2016-12-15 Piedmont Pharmaceuticals Llc Injectable antibiotic formulations and use thereof

Also Published As

Publication number Publication date
CA2988575A1 (en) 2016-12-15
ES2882578T3 (es) 2021-12-02
US20220031724A1 (en) 2022-02-03
EP3307275B1 (en) 2021-05-26
EP3307275A1 (en) 2018-04-18
EP3307275A4 (en) 2019-01-09
CA2988575C (en) 2024-04-16
US20230226091A1 (en) 2023-07-20
US12357648B2 (en) 2025-07-15
AU2016274949A1 (en) 2018-01-04
US20190216836A1 (en) 2019-07-18
US10286003B2 (en) 2019-05-14
JP6777734B2 (ja) 2020-10-28
WO2016201259A1 (en) 2016-12-15
US10729709B2 (en) 2020-08-04
US11628180B2 (en) 2023-04-18
US20250387423A1 (en) 2025-12-25
AU2016274949B2 (en) 2021-07-15
US12005071B2 (en) 2024-06-11
US20200352971A1 (en) 2020-11-12
JP2018516991A (ja) 2018-06-28
US20160361336A1 (en) 2016-12-15
US20240285662A1 (en) 2024-08-29

Similar Documents

Publication Publication Date Title
GB2546350B (en) Compositions and methods
ZA201802125B (en) Pharmaceutical composition and application thereof
IL254552A0 (en) Polycyclic carbamoylpyridone compounds and their pharmaceutical uses
GB201411197D0 (en) Composition and use thereof
PT3018183T (pt) Composição à base de halo-olefina e sua utilização
GB201718876D0 (en) Antithrombin-heparin compositions and methods
PL3133153T3 (pl) Nowy bakteriofag i zawierająca go kompozycja
ZA201703398B (en) Pharmaceutical composition and methods
PL3133151T3 (pl) Nowy bakteriofag i zawierająca go kompozycja
GB201411196D0 (en) Composition and use thereof
IL260321B (en) A multi-antigenic structure and a pharmaceutical preparation containing it
GB201502268D0 (en) Dental composition and use
SG10202106375UA (en) Pharmaceutical compositions and use thereof
PL3307275T3 (pl) Postacie użytkowe antybiotyków do wstrzykiwania i ich zastosowanie
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
GB201512996D0 (en) Compositions and methods
PL3135761T3 (pl) Nowy bakteriofag i zawierająca go kompozycja
IL248863A0 (en) Preparations containing il-31 and their use
GB201522814D0 (en) Compositions and uses thereof
GB201514413D0 (en) Compositions and methods
GB2545167B (en) Cloches and use thereof
IL256261B (en) Hide1 compositions and methods
GB201514770D0 (en) Compounds and their use
GB201500278D0 (en) Novel combination and use
GB201602665D0 (en) Compositions and their use